This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Healthylife.com.au is a generic brand of anastrozole prescribed by the Royal Pharmaceutical Society of Australia (RPS). In April 2020, Healthylife announced that it was splitting its generic brand Healthylife into its generic alternative and a biosimilar. The biosimilars are expected to be available in both generic and biosimilar versions in the first half of 2021. In June 2021, Healthylife announced that it had decided to sell its generic brand of Healthylife, Healthylife.au, its biosimilars and biosimilars alternatives, as well as its generic versions, into countries outside the US. Biosimilars are research-grade drugs that are approved by the US Food and Drug Administration (FDA) for treating a condition that hasn't been adequately treated for several months. The biosimilars are sold by Healthylife under the brand name Arimidex. In December 2017, Healthylife announced that it was abandoning its biosimilars in light of an agreement reached in November 2017 between Australia and the United States. In February 2018, Healthylife announced that it was selling its biosimilars under the name Anastrozole. Anastrozole is a synthetic version of the hormone oestrogen. Anastrozole contains the active ingredient anastrozole. Anastrozole is a brand-name prescription drug that contains the active ingredient anastrozole. Healthylife, Anastrozole and their Generic AlternativesHealthylife, Anastrozole and their Generic Alternatives and Generic S4 ingredients: ; anastrozole; anastrozole - sodium benzoate; anastrozole - propylene glycol monobac...
Healthylife, Anastrozole and their Generic Alternatives and Generic S4 ingredients: ; anastrozole; anastrozole - potassium edetate; anastrozole - sodium valerate; anastrozole - propylene glycol monobac...
Healthylife, Anastrozole and their Generic Alternatives and Generic S4 ingredients: ; anastrozole; anastrozole - potassium iodide; anastrozole - sodium iodide; anastrozole - potassium edetate; anastrozole - sodium iodide; anastrozole - propylene glycol monobac...
Healthylife, Anastrozole and their Generic Alternatives and Generic S4 ingredients: ; anastrozole; anastrozole - potassium hydroxide; anastrozole - magnesium stearate; anastrozole - methacrylic acid copolymer...
Healthylife.com.au is a generic brand of Anastrozole sold by Healthylife. Anastrozole is a synthetic form of the HGH (human chorionic gonadotropin) hormone.Salt Composition in both
Salt Composition
Anastrozole 1mg(same for both)
You Searched
Box of 28 tablets
We only sell the best substitute from top brands
Our Recommendation
Armotraz 1mg Tablet 10s
Strip of 10 tablets
2,038+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Request only request medical samples "Request medical samples " " " " " " " "Request medical samples"Is It Hard?Omron Hirth's breath test is a simple, safe test that can help you identify any underlying health issues. It's recommended that you see a doctor regularly to confirm that it's the right test for sure. It's not a controlled substance, so results cannot be guaranteed. It's a doctors professional, so you will receive personalized, medical advice to help you make the best decision for your health." "Doctors professional, so you will receive personalized, medical advice to help you make the best decision for your health." Doctors are trained to guide you, and if a test shows anything different, it's that of a doctor. Doctors are trained to guide you, and if a test shows anything different, it's that of a doctor. If you feel any health issues are contributing to your problems, you should consult a doctor first. Before you start a new treatment, let your doctor know if you are pregnant, breastfeeding, or planning a pregnancy. If they determine that yes, they will start you on a low dose of a hormone called FSH, which will help in the bedroom." "If you are pregnant or breastfeeding, let your doctor know before starting hormone replacement therapy (HRT). HRT is taken every third day, so it's important to follow the instructions on the drug label." "If you are taking any other medications, let your doctor know before starting HRT.
is an anti-estrogen that works by blocking the conversion of testosterone to estrogen. It is also known as Anastrozole or Arimidex.
Anastrozole is a drug which is prescribed for the treatment of breast cancer and other breast cancer types.
It is also known as Arimidex. However, it is a selective estrogen receptor modulator (SERM) and therefore does not have any estrogen-blocking effects. This means that it acts as a selective estrogen receptor blocker.
The dosage of Arimidex is taken once a day. It is not recommended to take more than 1 dose within a 24-hour period. The doctor or pharmacist will tell you how much of the dose you should take.
It is important to note that the amount of dose depends on the age, body weight and the type of cancer being treated.
The maximum daily dose for this type of cancer is 1,200 mg.
There are many benefits of using Arimidex to treat breast cancer. It is a type of aromatase inhibitor that reduces the production of estrogen in the body. It also helps in treating post-menopausal women with osteoporosis. These benefits are more noticeable when used in combination with other drugs.
However, the side effects are usually mild and go away with time. The most common side effects of Arimidex are nausea and vomiting.
It is important to note that Arimidex should not be used if you are taking a steroid medication, such as tamoxifen, for a long period of time.
In addition, it is important to remember that Arimidex is not a cure for breast cancer. Instead, it helps to treat breast cancer in the long term. It works by blocking the production of estrogen.
Your doctor will determine the correct dose for you. You should take Arimidex at the same time each day. Do not take more than one dose in a 24-hour period.
You should take Arimidex exactly as prescribed by your doctor. Take Arimidex with or without food.
To treat breast cancer, the doctor will decide the dose that best meets your medical needs.
It is important to follow the doctor’s instructions for the correct dosage and to take Arimidex regularly. It is also important to tell your doctor about any other medicines you are taking.
Some of the common side effects of Arimidex include nausea, stomach pain, bloating and gas.
If you have any further questions about Arimidex, you can also contact the atarimidexrx website.
Weis a website that connects you with a number of doctors and urologists. It connects you with a variety of urologists and specialists who have expertise in treating different types of cancer.
Your doctor will decide the dosage and how much of the dose you should take. Arimidex can also be used to treat breast cancer, but it is not an effective drug for this use. There is no known drug for breast cancer.
The dosage of Arimidex varies depending on the type of cancer being treated. For example, for estrogen-positive breast cancer, it is often prescribed to 1-2 mg per day.
However, you can take Arimidex as an estrogen-blocking drug for up to 12 weeks, which may be necessary for some types of cancer.
Arimidex is known to have some side effects. However, they are usually mild and go away with time. Most side effects are mild and go away with time.
The most common side effects of Arimidex are nausea, stomach pain, and vomiting.
Other common side effects of Arimidex include headache, dizziness, and fatigue.
If you experience any of these side effects, you should stop taking Arimidex and call your doctor. There are some precautions to be aware of when using Arimidex.
INDIANAPOLIS, IL.– A study has found that the aromatase inhibitor, anastrozole, is associated with reduced rates of gynecomastia, a gynecomastial disease.
AstraZeneca said the study, which was conducted by researchers at the San Diego School of Medicine, showed that aromatase inhibitors, used in aromatase inhibitor, anastrozole, and anastrozole and anastrozole and anastrozole and anastrozole aromatase inhibitors, can reduce the incidence of gynecomastia.
The study authors noted that, compared to placebo, aromatase inhibitors increased the risk of gynecomastia. They said they believe aromatase inhibitors may increase the likelihood of developing gynecomastia.
“In this study, we found that aromatase inhibitors are associated with a reduction in gynecomastia,” said lead study investigator Dr. David S. Denton, MD, of the University of Pennsylvania School of Medicine.
Aromatase inhibitors may reduce the risk of gynecomastia by up to 75%. This may be especially true for women who are or may become breast-feeding.
The study also found that aromatase inhibitors may also reduce the risk of other health problems.
The FDA approved anastrozole for use in breast cancer treatment in 1992, but the drug is not yet available in the United States.
In the study, the researchers used an in-house compound, which is similar to the drug, Arimidex, to determine the effect of aromatase inhibitors on breast cancer risk.
They found that aromatase inhibitors may reduce the risk of gynecomastia by up to 75%.
The study authors said that the FDA is taking a new look at aromatase inhibitors’ effects on the breast.
“Our goal is to find out if the aromatase inhibitor, anastrozole, is associated with a reduction in breast cancer risk,” said Dr. Michael K. Greenblatt, MD, of the University of North Carolina, Chapel Hill.
In the study, the researchers compared estrogen, anastrozole and anastrozole and anastrozole and anastrozole and anastrozole aromatase inhibitors, with estrogen and estrogen and and estrogen and anastrozole and anastrozole and anastrozole aromatase inhibitors aromatase inhibitors, all of which are used to treat breast cancer.
The research was conducted by researchers at the San Diego School of Medicine and was published in the Journal of the American Medical Association.
Image:The San Diego School of Medicine is a division of AstraZeneca. The study was published June 10. The authors are Dr. David Denton of the University of Pennsylvania School of Medicine and Dr. Greenblatt of the University of North Carolina at Chapel Hill.
The researchers found that the aromatase inhibitor, anastrozole, is associated with a reduction in gynecomastia, a gynecomastial disease.
They also said they believe aromatase inhibitors may increase the likelihood of developing gynecomastia.
The researchers said that, compared to placebo, aromatase inhibitors may also reduce the risk of other health problems.
David Denton of the University of Pennsylvania School of Medicine.
In the study, the researchers conducted a randomized, double-blind, placebo-controlled trial to determine whether the aromatase inhibitor, anastrozole, may reduce the risk of gynecomastia.
Stade de France Pharmacy